Cabaletta Bio Inc (CABA)

$2.86 -$0.30 (-9.49%) 4:37 PM 12/10/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $161.05M
  • Day's Range

    $2.79 - $3.10
  • Volume

    6,395,035
  • 52 Week Low / High

    $1.76 - $26.35
  • PE Ratio

    -
  • PEG Ratio

    -
  • Dividend Frequency

    -

CABA's Dividend
-
Amount
-
Dividend Yield
Nov 30
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
10
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
$25.29
Target Price

Company News

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

  • State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024

    Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...

Similar Stocks

  • ACHV.US Logo

    ACHV

    Achieve Life Sciences Inc

  • ADAP.US Logo

    ADAP

    Adaptimmune Therapeutics Plc

  • BDTX.US Logo

    BDTX

    Black Diamond Therapeutics Inc

  • SGMT.US Logo

    SGMT

    Sagimet Biosciences Inc. Series A Common Stock

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free